|
|
Volumn 20, Issue 2, 2001, Pages 5-15
|
|
Current and emerging treatment for congenital diaphragmatic hernia.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
NITRIC OXIDE;
STEROID;
AFTERCARE;
CESAREAN SECTION;
DIAPHRAGM HERNIA;
EXTRACORPOREAL OXYGENATION;
HIGH FREQUENCY VENTILATION;
HUMAN;
INCIDENCE;
LIGATION;
LUNG TRANSPLANTATION;
METHODOLOGY;
MORBIDITY;
NEWBORN INTENSIVE CARE;
PATHOPHYSIOLOGY;
PATIENT SELECTION;
POSTNATAL CARE;
PRENATAL CARE;
PROGNOSIS;
REVIEW;
TRACHEA;
HERNIA, DIAPHRAGMATIC;
AFTERCARE;
ANTI-INFLAMMATORY AGENTS;
CESAREAN SECTION;
EXTRACORPOREAL MEMBRANE OXYGENATION;
HIGH-FREQUENCY VENTILATION;
HUMANS;
INCIDENCE;
INTENSIVE CARE, NEONATAL;
LIGATION;
LUNG TRANSPLANTATION;
MORBIDITY;
NITRIC OXIDE;
PATIENT SELECTION;
POSTNATAL CARE;
PRENATAL CARE;
PROGNOSIS;
STEROIDS;
TRACHEA;
|
|
EID: 0035279938
PISSN: 07300832
EISSN: None
Source Type: Journal
DOI: 10.1891/0730-0832.20.2.5 Document Type: Review |
|
Times cited : (6)
|
|
References (61)
|
